Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

RASSF1C Inhibitors

RASSF1C inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of RASSF1C, one of the alternatively spliced isoforms of the Ras Association Domain Family 1 (RASSF1) gene. RASSF1 is involved in regulating critical cellular processes such as apoptosis, cell cycle progression, and cytoskeletal dynamics. Unlike the better-known RASSF1A isoform, RASSF1C has distinct regulatory functions and interacts with different sets of molecular partners. As a member of the RASSF1 family, RASSF1C plays a role in modulating cellular responses to external stimuli, particularly in pathways related to cell growth, differentiation, and apoptosis. Inhibitors of RASSF1C work by binding to its functional domains, thereby interfering with its ability to interact with key proteins and signaling pathways that regulate these processes.

The inhibition of RASSF1C leads to changes in the signaling pathways it influences, particularly those that manage cell growth and survival. By blocking RASSF1C's involvement in protein-protein interactions and downstream signaling cascades, these inhibitors prevent the normal regulation of cellular responses to environmental cues. This can result in altered cellular behavior, such as disruptions in cell cycle control, apoptosis, or cytoskeletal organization. Researchers use RASSF1C inhibitors to investigate the specific functions of this isoform in comparison to other RASSF1 family members, particularly to better understand the diversity of roles played by each isoform. These inhibitors help to shed light on the broader Ras-related pathways and their regulation by RASSF1C, offering insights into how specific isoforms contribute to fine-tuning cellular homeostasis and the balance between growth and programmed cell death. By studying RASSF1C inhibitors, scientists can gain deeper knowledge of the molecular mechanisms involved in cellular regulation, particularly in terms of how alternative splicing can produce functionally distinct proteins within the same gene family.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine could downregulate RASSF1C by causing hypomethylation of its gene promoter, thereby leading to the suppression of its transcription.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

5-Aza-2′-Deoxycytidine may reduce RASSF1C levels by inhibiting DNA methyltransferases, which results in the demethylation of gene promoters including potentially that of RASSF1C.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid may decrease RASSF1C transcription by increasing the acetylation of histones associated with its gene, leading to a more open and less transcriptionally active chromatin structure.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A has the potential to inhibit RASSF1C expression by altering histone deacetylase activity, resulting in chromatin remodeling that can suppress gene transcription.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

Romidepsin could downregulate RASSF1C by inhibiting histone deacetylases, which may lead to a condensed chromatin structure around the RASSF1C gene, thus reducing its expression.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

Panobinostat may lead to a decrease in RASSF1C expression by inhibiting histone deacetylase enzymes, thereby affecting the chromatin accessibility for transcription factors.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Valproic acid could inhibit RASSF1C by preventing the deacetylation of histones, which is essential for tight chromatin packing and suppression of gene transcription.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate could lead to the downregulation of RASSF1C by interfering with the folate pathway, thus reducing the methyl donor supply necessary for the methylation of its gene promoter.

Hydralazine-15N4 Hydrochloride

304-20-1 (unlabeled)sc-490605
1 mg
$480.00
(0)

Hydralazine may decrease RASSF1C expression by inducing hypomethylation of DNA, including the promoter regions of genes such as RASSF1C.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Disulfiram could lead to the downregulation of RASSF1C expression by inhibiting enzymes involved in DNA methylation and histone modification processes associated with gene silencing.